ARQ 501 in Combination With Docetaxel in Patients With Cancer
Clinical trial NCT00099190 · COMPLETED
Trial details
- NCT number
- NCT00099190
- Sponsor
- ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2006-11-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.